Pharm-Olam Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 852

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 2

  • Investments
  • 2

Pharm-Olam General Information

Description

Provider of contract research services designed to deliver right-sized trial services to pharmaceutical, biotechnology, government and public health organizations. The company specializes in small molecule therapies and biologics in oncology-hematology, rare disease, allergy, autoimmune, infectious disease and vaccines, enabling a healthier world through agile, innovative and customized clinical research organization solutions for Phase one to four research.

Contact Information

Website
www.pharm-olam.com
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Other Healthcare Services
Acquirer
Allucent (Cary)
Primary Office
  • 450 North Sam Houston Parkway East
  • Suite 250
  • Houston, TX 77060
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharm-Olam Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pharm-Olam‘s full profile, request access.

Request a free trial

Pharm-Olam Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of contract research services designed to deliver right-sized trial services to pharmaceutical, biotechnology,
Other Healthcare Services
Houston, TX
852 As of 2022
00000
000000000000 00000

000000

commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit es
00000 0000000000 000
Collyer Quay, Singapore

000000

ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate ve
0000 000000000
Durham, NC
00000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pharm-Olam Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Clinexa Life Sciences Corporation Collyer Quay, Singapore
0000000 0000000000 Private Equity-Backed Durham, NC 00000 00000 000000000 00000
00000000 Private Equity-Backed Southborough, MA 000 000000000
000000000 Corporation Saratoga Springs, NY 00
0000000 Private Equity-Backed Miami, FL 000 00.000 00000000000
You’re viewing 5 of 14 competitors. Get the full list »

Pharm-Olam Board Members (5)

Name Representing Role Since
000000000 000000 Self Board Member 000 0000
You’re viewing 1 of 5 board members. Get the full list »

Pharm-Olam Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pharm-Olam Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pharm-Olam‘s full profile, request access.

Request a free trial

Pharm-Olam Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 14-Dec-2011 0000000000 Other Services (B2C Non-Financial) 0000 0000
Eleison Pharmaceuticals 26-May-2011 Corporate 000 Drug Discovery
To view Pharm-Olam’s complete investments and acquisitions history, request access »